Maxwell Tran always believed in the power of art to affect social change. Now he's striving to inspire other young artists to use their talents for good.
The 19-year old Mississauga native was recently named to Plan Canada's Top 20 Under 20 for his efforts to grow and promote Ink Movement — a non-profit organization that was conceived to empower youth through the arts.
"I was an avid writer in high school, and I noticed right away there aren't the same kind of networking opportunities for youth working in the arts as there are in business and health sciences," says Tran, a third-year student in the Bachelor of Health Sciences Program (BHSc) with an interest in researching chronic disease and global health.
Two new studies led by researchers from the Farncombe Family Digestive Health Research Institute at McMaster University show that transplantation of fecal matter may be a useful tool in the fight against ulcerative colitis (UC).
Ulcerative colitis is a chronic, debilitating inflammatory bowel condition characterized by symptoms including bloody stools, diarrhea, abdominal pain, weight loss and malnutrition. It results from the development of abnormal immune responses to the normal bacteria in the digestive tract. It is difficult to treat and standard therapy doesn’t always work.
There is currently great interest in treating UC with fecal microbiota transplantation (FMT), which involves transplanting gut fecal bacteria from healthy people into patients with UC.
A study led by associate professor of medicine Elena Verdu that was recently published in Inflammatory Bowel Diseases found that UC can be controlled by the type of bacteria that inhabits the gut. Along the same theme, in research published on June 29 in Gastroenterology, professor of medicine Paul Moayyedi and his team explored the safety and efficacy of FMT by conducting a placebo-controlled, randomized trial.